Skip to content
etf.net

PSCH

GradeBNASDAQ

Invesco S&P SmallCap Health Care ETF

Sectors · Invesco · Inception 2010-04-07 · SEC filings

$52.54−1.22 (−2.26%)

As of Sep 23, 2026, 2:20 PM EDT

Intraday session: down, 59 prints from 53.76 to 52.54. Range 52.54 to 53.69. Use the arrow keys to read each point.$53.00$53.5010 AM12 PM2 PM4 PM
Expense ratio
0.29%
Fund size
$185M
1Y return
+28.9%
Yield · Last 12 months
0.00%
Holdings
70
Volume · 30D
0M sh
NAV per share
$53.26
52W range
low $39.08high $56.45

The ETF.net PSCH Grade

B

67/ 100

Rank 7 of 25 in Health Care (Broad)⁠

Confidence Medium

Six-pillar profile for PSCH. Scores out of 100: Cost 88, Risk 48, Mission not scored, Tradability 47, Holdings 74, Durability 61. Strongest: Cost (88). Weakest: Tradability (47). Based on 5 of 6 pillars.
F< 25
D≥ 25
C≥ 40
B≥ 55
A≥ 70

Score 67 of 100 sits in the B band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.

  • Cost

    What you pay to own it — the expense ratio plus trading frictions, ranked within its category.
    AScore 88
    Category rank4/25 · top 16%

  • Mission

    How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.
    Not scored
    —

  • Risk

    How violently it can move — volatility, drawdown depth, and downside capture versus its category.
    CScore 48
    Category rank15/24 · mid-pack

  • Tradability

    How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.
    CScore 47
    Category rank14/25 · mid-pack

  • Holdings

    What it actually owns — the quality, breadth, and concentration of the underlying portfolio.
    AScore 74
    Category rank8/25 · top 32%

  • Durability

    Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.
    BScore 61
    Category rank13/25 · mid-pack

Graded as of Sep 22, 2026 · Based on 5 of 6 pillars

Our read on PSCH

ETF.net Research

BHealth care, minus the mega-cap pharma giants. PSCH tracks a capped small-cap health care index from the S&P SmallCap 600: roughly 70 companies, same sector as the household-name funds, opposite end of the size spectrum, for 0.29% a year.

Stated mandate

The Fund is based on the S&P SmallCap 600® Capped Health Care Index and normally invests at least 90% of its assets in securities represented by that Index.

Why people hold it

  1. 01Charges 0.29% a year, well below the median fee in its broad health care peer group. Cheap access to the small-cap corner of the sector.
  2. 02Rules-based and plain: normally at least 90% of assets in the securities of the S&P SmallCap 600 Capped Health Care Index, roughly 70 names, with index caps limiting how large any one position gets.
  3. 03Running since 2010, through multiple biotech boom-and-bust cycles, and one of the stronger builds among the two dozen broad health care ETFs we track.

Worth knowing

  1. 01Trades lightly next to the mega-cap sector funds, so bid-ask spreads and market impact matter more here, particularly in size or in a fast-moving market.
  2. 02Small-cap health care is the jumpy end of the sector, and a roughly 70-stock lineup means single-company news lands harder than in a sprawling mega-cap fund.
  3. 03Distributions come once or twice a year, not monthly. This is a sector equity sleeve, not an income-first holding.

PSCH Holdings

As of Sep 20, 2026, 1:49 PM
Asset class
Stocks
Holdings
70
Top-10 weight
37%
Largest holding
CORT5.5%

Sectors

  • Health Care98.9%
  • Financials1.1%

Geography

  • United States96.20%
  • Ireland3.80%
The fund’s holdings, weight-ordered — page 1 of 5.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001CORTCorcept Therapeutics Inc5.54%92,233$10M147
002GKOSGlaukos Corp5.05%56,678$9M123
003PTGXProtagonist Therapeutics Inc4.54%58,344$8M137
004TGTXTG Therapeutics Inc3.94%127,237$7M129
005ALKSAlkermes PLC3.80%160,897$7M151
006LGNDLigand Pharmaceuticals Inc2.99%19,354$5M133
007TFXTeleflex Inc2.90%42,727$5M112
008PTCTPTC Therapeutics Inc2.85%80,077$5M136
009RDNTRadNet Inc2.83%68,316$5M116
010MMSIMerit Medical Systems Inc2.68%57,583$5M136
011LQDALiquidia Corp2.47%67,793$5M112
012ITGRInteger Holdings Corp2.25%32,757$4M109
013INDVIndivior Pharmaceuticals Inc2.23%117,679$4M127
014CONConcentra Group Holdings Parent Inc2.22%114,867$4M128
015ICUIICU Medical Inc2.01%24,144$4M113

Showing 1–15 of 72 holdings

PSCH Performance

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

PSCH$12,889
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,723
Sep 22, 2025 to Sep 22, 2026. PSCH $12,889. SPY $11,723. Use the arrow keys to read each point.$9,067$11,436$13,806Sep 2025Mar 2026Sep 2026

Sep 22, 2025 – Sep 22, 2026

Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for PSCH. Periods over one year show the average yearly return.
PeriodPSCH
Year to date+22.0%
1 month−3.4%
3 months+10.5%
1 year+28.9%
3 years+12.5%per year
5 years−2.7%per year
10 years+7.7%per year

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for PSCH
YearReturn barPSCH
2026 YTD+22.0%
2025−0.5%
2024+3.8%
2023−2.7%
2022−26.5%
2021+5.8%
2020+31.5%

PSCH in the news

ETF.net Research hasn’t filed on PSCH yet — coverage lands here as it’s written.

PSCH Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Sep 22, 2026.
0.00%Last 12 months
Payout per share
$0.00033Last 12 months
Last payment
$0.00033 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Twice a year

Distribution history

2017–2026

One bar per payment. 9 payments from 2017 to 2026 YTD. Sep 24, 2018 $0.0017; Dec 18, 2023 $0.0045; Mar 18, 2024 $0.04; Jun 24, 2024 $0.07; Dec 23, 2024 $0.02; Mar 24, 2025 $0.01; Jun 23, 2025 $0.002; Sep 22, 2025 $0.0026; Mar 23, 2026 $0.00033. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Mar 23, 2026Mar 27, 2026$0.00033
Sep 22, 2025Sep 26, 2025$0.0026
Jun 23, 2025Jun 27, 2025$0.002
Mar 24, 2025Mar 28, 2025$0.01
Dec 23, 2024Dec 27, 2024$0.02
Jun 24, 2024Jun 28, 2024$0.07
Mar 18, 2024Mar 22, 2024$0.04
Dec 18, 2023Dec 22, 2023$0.0045
Sep 24, 2018Sep 28, 2018$0.0017
Dec 16, 2016Dec 30, 2016$0.0065
Dec 24, 2014Dec 31, 2014$0.48
Dec 19, 2014Dec 31, 2014$0.0092

PSCH Risk

How much the fund’s monthly returns vary, scaled to a year.
21.9%
Annualised · 36 months to Aug 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.33
vs 3-month T-bills · to Aug 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−45.8%
Trough Oct 2023
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.96
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

PSCH Cost

Expense ratio0.29%
  • The middle half of Health Care (Broad) funds
  • Median 0.50%

3 of the 25 Health Care (Broad) funds charge less.

PSCH costs $29.00 a year on $10,000. The median Health Care (Broad) fund costs $50.00.